time_published,title,sentiment_score,sentiment_label,ticker
2025-10-13 13:05:00,"CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - Cumberland  ( NASDAQ:CPIX ) ",0.041476,Neutral,CPIX
2025-09-08 11:00:00,"Sitryx appoints Adam Mostafa as Chief Financial Officer - Cumberland  ( NASDAQ:CPIX ) , Abpro Hldgs  ( NASDAQ:ABP ) ",0.259721,Somewhat-Bullish,CPIX
2025-08-06 19:48:01,Cumberland  ( CPIX )  Q2 Revenue Up 10%,0.269295,Somewhat-Bullish,CPIX
2025-08-04 13:05:00,CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK - Cumberland  ( NASDAQ:CPIX ) ,0.07227,Neutral,CPIX
2025-03-06 13:35:00,"Idiopathic Pulmonary Fibrosis Market Size is Expected to Reach USD 9.23 Billion by 2033, Growing at a CAGR of 7.35%: Straits Research",0.092532,Neutral,CPIX
2025-02-04 18:31:48,Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease - Cumberland  ( NASDAQ:CPIX ) ,0.171921,Somewhat-Bullish,CPIX
2024-12-10 19:00:50,"S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings - AutoZone  ( NYSE:AZO ) , Chimerix  ( NASDAQ:CMRX ) ",0.094697,Neutral,CPIX
2024-12-10 17:37:56,"Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Cumberland  ( NASDAQ:CPIX ) , Chimerix  ( NASDAQ:CMRX ) ",0.179798,Somewhat-Bullish,CPIX
2024-12-10 17:08:21,Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? - Cumberland  ( NASDAQ:CPIX ) ,0.032092,Neutral,CPIX
2024-12-10 14:49:24,"Dow Falls 150 Points; Oracle Posts Downbeat Results - Biora Therapeutics  ( NASDAQ:BIOR ) , Chimerix  ( NASDAQ:CMRX ) ",0.111166,Neutral,CPIX
2024-12-10 11:05:29,"Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - C3.ai  ( NYSE:AI ) , Asset Entities  ( NASDAQ:ASST ) ",0.070299,Neutral,CPIX
2024-07-13 05:28:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated by Analysts at StockNews.com,0.096096,Neutral,CPIX
2024-07-05 05:28:42,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Research Coverage Started at StockNews.com,0.083779,Neutral,CPIX
2024-06-27 05:34:47,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.095726,Neutral,CPIX
2024-06-19 05:36:44,StockNews.com Initiates Coverage on Cumberland Pharmaceuticals  ( NASDAQ:CPIX ) ,0.138537,Neutral,CPIX
2024-06-11 08:36:50,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by Analysts at StockNews.com,0.117208,Neutral,CPIX
2024-06-03 07:34:12,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Research Coverage Started at StockNews.com,0.090764,Neutral,CPIX
2024-05-26 05:24:41,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by Analysts at StockNews.com,0.095749,Neutral,CPIX
2024-05-10 12:14:29,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.050328,Neutral,CPIX
2024-05-07 20:05:00,Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update,0.062823,Neutral,CPIX
2024-05-06 13:16:12,StockNews.com Begins Coverage on Cumberland Pharmaceuticals  ( NASDAQ:CPIX ) ,0.081658,Neutral,CPIX
2024-04-16 06:28:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.214411,Somewhat-Bullish,CPIX
2024-04-08 06:20:42,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated by Analysts at StockNews.com,0.172831,Somewhat-Bullish,CPIX
2024-03-31 06:24:44,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Earns Hold Rating from Analysts at StockNews.com,0.236797,Somewhat-Bullish,CPIX
2024-03-23 06:28:47,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.225655,Somewhat-Bullish,CPIX
2024-03-15 07:08:46,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated by Analysts at StockNews.com,0.259766,Somewhat-Bullish,CPIX
2024-03-07 07:28:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by Analysts at StockNews.com,0.196688,Somewhat-Bullish,CPIX
2024-02-28 07:21:28,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Earns Hold Rating from Analysts at StockNews.com,0.184552,Somewhat-Bullish,CPIX
2024-02-28 07:20:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Earns Hold Rating from Analysts at StockNews.com,0.159261,Somewhat-Bullish,CPIX
2024-01-11 06:32:45,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by Analysts at StockNews.com,0.237035,Somewhat-Bullish,CPIX
2023-12-26 06:26:45,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by StockNews.com,0.248001,Somewhat-Bullish,CPIX
2023-12-19 07:50:42,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.254079,Somewhat-Bullish,CPIX
2023-12-10 06:54:42,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated at StockNews.com,0.241195,Somewhat-Bullish,CPIX
2023-11-25 09:20:52,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.226456,Somewhat-Bullish,CPIX
2023-11-16 08:28:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated at StockNews.com,0.205353,Somewhat-Bullish,CPIX
2023-11-08 08:18:45,StockNews.com Initiates Coverage on Cumberland Pharmaceuticals  ( NASDAQ:CPIX ) ,0.164113,Somewhat-Bullish,CPIX
2023-10-31 07:26:46,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Research Coverage Started at StockNews.com,0.210127,Somewhat-Bullish,CPIX
2023-10-23 07:26:44,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.17327,Somewhat-Bullish,CPIX
2023-10-23 07:26:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Now Covered by StockNews.com,0.157094,Somewhat-Bullish,CPIX
2023-10-15 07:16:42,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Research Coverage Started at StockNews.com,0.246772,Somewhat-Bullish,CPIX
2023-10-07 07:30:50,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Earns Hold Rating from Analysts at StockNews.com,0.264716,Somewhat-Bullish,CPIX
2023-10-05 21:01:00,"Diffuse Cutaneous Systemic Sclerosis Market to Proliferate at a Considerable Growth Rate by 2032, Estimates DelveInsight | Leading Companies in the Market - Kyowa Kirin Acceleron, Cumberland, Horizon, CSL Behring, Seagen, Janssen",0.061731,Neutral,CPIX
2023-09-29 07:24:44,StockNews.com Initiates Coverage on Cumberland Pharmaceuticals  ( NASDAQ:CPIX ) ,0.212122,Somewhat-Bullish,CPIX
2023-09-21 07:34:44,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Receives New Coverage from Analysts at StockNews.com,0.062831,Neutral,CPIX
2023-09-14 21:01:00,"Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - GlaxoSmithKline, AstraZeneca, Sanofi, Roche, Amgen, Regeneron, Incyte, Areteia, Suzhou Connect, Cumberland, Pulmatrix",0.116778,Neutral,CPIX
2023-09-14 09:06:43,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated by Analysts at StockNews.com,0.267479,Somewhat-Bullish,CPIX
2023-09-09 06:46:17,Cumberland Pharmaceuticals Receives Hold Rating in Recent Coverage,0.247184,Somewhat-Bullish,CPIX
2023-09-05 07:24:49,StockNews.com Begins Coverage on Cumberland Pharmaceuticals  ( NASDAQ:CPIX ) ,0.310165,Somewhat-Bullish,CPIX
2023-09-01 14:34:00,Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research,0.110872,Neutral,CPIX
2023-08-28 06:42:50,Cumberland Pharmaceuticals  ( NASDAQ:CPIX )  Coverage Initiated by Analysts at StockNews.com,0.326504,Somewhat-Bullish,CPIX
